Results 21 to 30 of about 138,886 (226)
Clinical Case Reports, 2023 Key Clinical Message Visceral leishmaniasis and hemophagocytic lymphohistiocytosis share many features in common and may coincide in the same patient. Timely diagnosis and management of visceral leishmaniasis could save patients from unnecessary toxic ...
Anwar I. Joudeh +6 more
doaj +1 more source
Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
Journal of Tropical Medicine, 2021 Visceral leishmaniasis, also known as kala-azar is one of the most commonly neglected tropical diseases affecting a large number of rural and resource-limited people in South Asia, Africa, and South America.
Pashupati Pokharel +2 more
doaj +1 more source
Immunobiology of visceral leishmaniasis [PDF]
Frontiers in Immunology, 2012 Visceral leishmaniasis (VL), commonly known as kala-azar, is caused by Leishmania donovani and Leishmania infantum (Leishmania chagasi in the Americas). These Leishmania species infect macrophages throughout the viscera, and parasites are typically found in the spleen, liver, and bone marrow.
Kumar, Rajiv, Nylén, Susanne
openaire +3 more sources
Gates Open Research, 2019 Visceral leishmaniasis (VL) is a neglected tropical disease (NTD) caused by Leishmania protozoa that are transmitted by female sand flies. On the Indian subcontinent (ISC), VL is targeted by the World Health Organization (WHO) for elimination as a public
NTD Modelling Consortium Visceral Leishmaniasis Group
doaj +1 more source
Diagnosis of visceral leishmaniasis [PDF]
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2011 Leishmaniasis is a vector-borne disease with up to 350 million people at risk of infection worldwide. Among its different clinical manifestations, visceral is the most severe form. Since clinical features of visceral leishmaniasis (VL) mimic several other common diseases, accurate diagnosis is crucial as the treatment is associated with significant ...
Pankaj, Srivastava +3 more
openaire +2 more sources
Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity
Microorganisms, 2021 Leishmaniasis, a chronic and persistent intracellular protozoal infection caused by many different species within the genus Leishmania, is an unfamiliar disease to most North American providers.
John M. Curtin, Naomi E. Aronson
doaj +1 more source
Oral miltefosine for Indian visceral leishmaniasis. [PDF]
, 2002 BACKGROUND: There are 500,000 cases per year of visceral leishmaniasis, which occurs primarily in the Indian subcontinent. Almost all untreated patients die, and all the effective agents have been parenteral.
Berman, Jonathan +10 more
core +1 more source
Kidney involvement in leishmaniasis—a review
Brazilian Journal of Infectious Diseases, 2014 Leishmaniasis is an infectious disease caused by protozoa of the genus Leishmania transmitted by insects of the genus Lutzomyia sp. or Phlebotomus sp.
Geraldo Bezerra da Silva Junior +2 more
doaj +1 more source
Visceral leishmaniasis in eastern Africa--current status. [PDF]
, 2007 Visceral leishmaniasis (VL) is among the most neglected of the tropical diseases, afflicting the poorest of the poor. In eastern Africa, VL causes at least 4000 deaths annually, a loss of approximately 385,000 disability-adjusted life years.
Reithinger, Richard +3 more
core +1 more source
BMC Public Health, 2017 Background There is paucity of data on quality of life as a dimension of treatment outcome among Visceral Leishmaniasis and HIV coinfected patients. This study sought to explore perceived quality of life among Visceral Leishmaniasis and HIV coinfected ...
Mekuriaw Alemayehu +3 more
doaj +1 more source